Variant report
Variant | nsv893645 |
---|---|
Chromosome Location | chr9:104992089-105046926 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:82)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:13)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr9:105045700-105045900 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr9:104999513-104999769 | HepG2 | liver: | n/a | chr9:104999628-104999639 |
3 | CEBPB | chr9:105015369-105015524 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | CEBPB | chr9:105045628-105045943 | HepG2 | liver: | n/a | n/a |
5 | CTCF | chr9:105015460-105015610 | HEK293 | kidney: | n/a | chr9:105015565-105015573 |
6 | CTCF | chr9:105015420-105015729 | H1-hESC | embryonic stem cell: | n/a | chr9:105015565-105015573 |
7 | CTCF | chr9:105015408-105015699 | H1-hESC | embryonic stem cell: | n/a | chr9:105015565-105015573 |
8 | CTCF | chr9:105015460-105015610 | MCF-7 | breast: | n/a | chr9:105015565-105015573 |
9 | CTCF | chr9:105018830-105018903 | GM10266 | blood: | n/a | n/a |
10 | CTCF | chr9:104997625-104997683 | Fibrobl | skin: | n/a | n/a |
11 | CTCF | chr9:105015560-105015710 | WERI-Rb-1 | eye: | n/a | chr9:105015565-105015573 |
12 | CTCF | chr9:105019456-105019525 | GM13976 | blood: | n/a | n/a |
13 | CTCF | chr9:105015517-105015635 | MCF-7 | breast: | n/a | chr9:105015565-105015573 |
14 | CTCF | chr9:105029673-105029679 | GM10248 | blood: | n/a | n/a |
15 | CTCF | chr9:105007369-105007413 | GM20000 | blood: | n/a | n/a |
16 | CTCF | chr9:105015420-105015570 | Caco-2 | colon: | n/a | n/a |
17 | CTCF | chr9:105015540-105015690 | WERI-Rb-1 | eye: | n/a | chr9:105015565-105015573 |
18 | CTCF | chr9:105039793-105039858 | Kidney_OC | kidney: | n/a | n/a |
19 | CTCF | chr9:105015506-105015634 | MCF-7 | breast: | n/a | chr9:105015565-105015573 |
20 | CTCF | chr9:105017180-105017330 | GM12866 | blood: | n/a | n/a |
21 | E2F4 | chr9:104995456-104995731 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | E2F4 | chr9:105041290-105041457 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | E2F4 | chr9:105006785-105007034 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | E2F4 | chr9:105046506-105046792 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | E2F4 | chr9:105018969-105019169 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | E2F4 | chr9:105036415-105036556 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | E2F4 | chr9:105025079-105025217 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | EGR1 | chr9:104999892-105000088 | K562 | blood: | n/a | n/a |
29 | EGR1 | chr9:104999898-105000117 | K562 | blood: | n/a | n/a |
30 | EP300 | chr9:105026378-105026917 | GM12878 | blood: | n/a | chr9:105026435-105026449 |
31 | EP300 | chr9:104999780-104999807 | GM12878 | blood: | n/a | n/a |
32 | FOS | chr9:105036246-105036626 | MCF10A-Er-Src | breast: | n/a | chr9:105036451-105036460 |
33 | FOS | chr9:105036247-105036631 | MCF10A-Er-Src | breast: | n/a | chr9:105036451-105036460 |
34 | FOS | chr9:105005505-105005531 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | FOS | chr9:105036308-105036641 | MCF10A-Er-Src | breast: | n/a | chr9:105036451-105036460 |
36 | FOS | chr9:105017646-105017952 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | FOS | chr9:105036291-105036608 | MCF10A-Er-Src | breast: | n/a | chr9:105036451-105036460 |
38 | FOS | chr9:105017647-105017981 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | FOS | chr9:105017660-105017923 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | GATA3 | chr9:105012859-105013100 | T-47D | breast: | n/a | chr9:105012908-105012917 |
41 | GTF2F1 | chr9:105015554-105015583 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | JUND | chr9:105002606-105002737 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | MAFK | chr9:105018716-105018720 | HepG2 | liver: | n/a | n/a |
44 | MAX | chr9:105011592-105011818 | NB4 | blood: | n/a | chr9:105011651-105011661 |
45 | MXI1 | chr9:104995047-104995110 | GM12878 | blood: | n/a | n/a |
46 | MXI1 | chr9:105015495-105015612 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | MYC | chr9:104999988-105000028 | NB4 | blood: | n/a | n/a |
48 | MYC | chr9:104997652-104997685 | MCF-7 | breast: | n/a | n/a |
49 | MYC | chr9:105045635-105045785 | MCF10A-Er-Src | breast: | n/a | chr9:105045692-105045703 chr9:105045692-105045703 chr9:105045692-105045702 chr9:105045692-105045703 chr9:105045691-105045704 |
50 | MYC | chr9:105036319-105036522 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:104998428..105001146-chr9:105002179..105004444,3 | K562 | blood: | |
2 | chr10:9229922..9230664-chr9:104997433..104997933,2 | MCF-7 | breast: | |
3 | chr9:104996734..105000664-chr9:105001906..105004565,3 | K562 | blood: | |
4 | chr9:104996734..105000664-chr9:105001906..105004565,3 | K562 | blood: | |
5 | chr9:104998428..105001146-chr9:105002179..105004444,3 | K562 | blood: |
(count:13 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C9orf107-2 | chr9:104997647-104997890 | FPKM1_group_33624_transcript_3 |
2 | lnc-C9orf107-6 | chr9:105022063-105022447 | NONHSAT133760 |
3 | lnc-C9orf107-2 | chr9:104997351-104999003 | FPKM1_group_33624_transcript_3 |
4 | lnc-C9orf107-2 | chr9:104998737-104998845 | XLOC_007494 |
5 | lnc-C9orf107-2 | chr9:105000314-105000407 | XLOC_007494 |
6 | lnc-C9orf107-5 | chr9:105045829-105045892 | NONHSAT133761 |
7 | lnc-C9orf107-6 | chr9:105022537-105022537 | FPKM1_group_33627_transcript_2 |
8 | lnc-C9orf107-6 | chr9:105022537-105022636 | NONHSAT133760 |
9 | lnc-C9orf107-2 | chr9:104997351-104999003 | NONHSAT133757 |
10 | lnc-GRIN3A-3 | chr9:105029817-105029914 | ucscGeneNc_uc004bbt_2 |
11 | lnc-C9orf107-6 | chr9:105022063-105022447 | FPKM1_group_33627_transcript_2 |
12 | lnc-C9orf107-2 | chr9:105000311-105000554 | NONHSAT133757 |
13 | lnc-GRIN3A-3 | chr9:105029817-105029914 | NONHSAT133756 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-329P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9644962 | chr9:104992089-104992090 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs192058799 | chr9:104992113-104992114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9644963 | chr9:104992119-104992120 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs530089441 | chr9:104992128-104992129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536640750 | chr9:104992259-104992260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs370477987 | chr9:104992263-104992264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563506888 | chr9:104992331-104992332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375367592 | chr9:104992387-104992388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532717989 | chr9:104992396-104992397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570386935 | chr9:104992428-104992429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552816502 | chr9:104992447-104992448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183152625 | chr9:104992468-104992469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555059164 | chr9:104992478-104992479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528084022 | chr9:104992488-104992489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs368278772 | chr9:104992501-104992502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144442305 | chr9:104992551-104992552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537099940 | chr9:104992670-104992671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557206351 | chr9:104992688-104992689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558565268 | chr9:104992719-104992720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570596006 | chr9:104992735-104992736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12350036 | chr9:104992762-104992763 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs146151620 | chr9:104992810-104992811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574979571 | chr9:104992834-104992835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541030365 | chr9:104992936-104992937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554502963 | chr9:104992961-104992962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574609253 | chr9:104992970-104992971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535745189 | chr9:104997352-104997353 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs554762055 | chr9:104997382-104997383 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs569448926 | chr9:104997387-104997388 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs140504945 | chr9:104997401-104997402 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs543709997 | chr9:104997403-104997404 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs556313523 | chr9:104997417-104997418 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs576371755 | chr9:104997419-104997420 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs572224914 | chr9:104997438-104997439 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs191265647 | chr9:104997440-104997441 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs565377254 | chr9:104997444-104997445 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs527734611 | chr9:104997473-104997474 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs541235967 | chr9:104997482-104997483 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs561112639 | chr9:104997485-104997486 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs530348879 | chr9:104997495-104997496 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs550433364 | chr9:104997496-104997497 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs58902315 | chr9:104997510-104997511 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs138300596 | chr9:104997518-104997519 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs142827548 | chr9:104997543-104997544 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs545702318 | chr9:104997558-104997559 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs534669398 | chr9:104997563-104997564 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs554823228 | chr9:104997582-104997583 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs1115733 | chr9:104997660-104997661 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs576042875 | chr9:104997673-104997674 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs558208883 | chr9:104997722-104997723 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Schizophrenia | 23813976 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:104991800-104992600 | Enhancers | Ovary | ovary |
2 | chr9:104992400-104992600 | Enhancers | Fetal Heart | heart |
3 | chr9:104992600-104993000 | Enhancers | Aorta | Aorta |
4 | chr9:104997400-104997600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
5 | chr9:104997800-104998800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr9:104998800-104999200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr9:105024600-105024800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
8 | chr9:105024600-105026200 | Enhancers | Fetal Kidney | kidney |
9 | chr9:105026200-105026800 | Weak transcription | Fetal Kidney | kidney |
10 | chr9:105026600-105027200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
11 | chr9:105026800-105027000 | Enhancers | Fetal Kidney | kidney |
12 | chr9:105032000-105032600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
13 | chr9:105032600-105036000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr9:105036000-105036200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr9:105036200-105036600 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr9:105036200-105037000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr9:105036600-105037000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
18 | chr9:105042400-105043000 | Enhancers | Fetal Kidney | kidney |
19 | chr9:105043000-105043600 | Weak transcription | Fetal Kidney | kidney |
20 | chr9:105043600-105043800 | Enhancers | Fetal Kidney | kidney |